Roth/MKM Downgrades Rain Oncology (RAIN) to Neutral 'Pending Outcome of Evaluation of Pipeline Expansion'
Tweet Send to a Friend
(Updated - May 30, 2023 10:10 AM EDT)
Roth/MKM analyst Kumaraguru Raja downgraded Rain Oncology (NASDAQ: RAIN) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Kumaraguru Raja downgraded Rain Oncology (NASDAQ: RAIN) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
